Glaucoma: Not just a phase

Last month, in a CET article looking at advances in intraocular pressure measurements, Dr Daniela Oehring explained how being able to measure intraocular pressure continuously over a 24 hour period ‘allows the eye care specialist to assess the effectiveness of any prescribed glaucoma treatment, allowing both the patient and the doctors to benefit from individually tailored therapy. It has been shown that 24-hour IOP monitoring results in an immediate treatment change in approximately 40% of the patients and a general clinical management change in about 80% of cases.’¹

Traditionally, continuous IOP monitoring (or phasing) required a patient to repeatedly visit or stay within a clinic facility to allow measurements to be made. Obviously, this had implications of cost, convenience and compliance. More recently, three devices have been introduced that allow phasing to be undertaken remotely, so avoiding these problems.